RACHAEL OBI: Open Payments
NPI 1760940001 · FONTANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 10 payments from 6 companies in 2025. Trend: 2023 $207 · 2024 $184 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 4 | $165 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $130 |
| Teva Pharmaceuticals USA, Inc. | 2 | $56 |
| Alkermes, Inc. | 1 | $27 |
| ABBVIE INC. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: INVEGA SUSTENNA, CAPLYTA, AUSTEDO XR, ARISTADA, VRAYLAR, COBENFY.
Industry payments across CA — which companies pay providers there.
